UNCY
Unicycive Therapeutics, Inc.
1W: -1.6%
1M: -3.5%
3M: +13.7%
YTD: +14.7%
1Y: +3.4%
3Y: -69.6%
$6.65
+0.26 (+4.07%)
After Hours: $6.67 (+0.01, +0.23%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$142.9M
52W Range3.71-11
Volume482,618
Avg Volume537,227
Beta1.82
Dividend—
Analyst Ratings
Company Info
CEOShalabh K. Gupta
Employees22
SectorHealthcare
IndustryBiotechnology
IPO Date2021-07-12
Websiteunicycive.com
4300 El Camino Real
Los Altos, CA 94022
US
Los Altos, CA 94022
US
650 351 4495
About Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
Latest News
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf
Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Receives Consensus Rating of “Moderate Buy” from Analysts
Important Notice to Long-Term Shareholders of Integer Holdings Corp. (NYSE: ITGR): Molina Healthcare, Inc. (NYSE: MOH); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Aggarwal Gaurav | C-Conversion | 652,900 | — | 2025-08-25 |
| Aggarwal Gaurav | D-Return | 3,199 | $4.90 | 2025-08-25 |
| Aggarwal Gaurav | A-Award | 21,200 | $4.71 | 2025-07-28 |
| Laumas Sandeep | A-Award | 21,200 | $4.71 | 2025-07-28 |
| Kenkare-Mitra Sara | A-Award | 21,200 | $4.71 | 2025-07-28 |